Point-of-Care Testing Market to Gain a Stronghold by 2026 Report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.
BriefingWire.com, 5/19/2021 - Market Scenario
Global Point-of-Care Testing Market (POC) was valued US$ 14Bn in 2017 and is anticipated to reach US$ 30Bn by 2026 at a CAGR of about 10.0% during a forecast.Global Point-of-Care Testing Market Global Point-of-Care (POC) Testing Market by product type, By Product Type, By End User and by region. Based on product type point of care market is segmented into Glucose Monitoring, Cardiac Markers, Infectious Diseases Testing, Cholesterol Testing, Coagulation Monitoring, Pregnancy And Fertility Testing, Haematology Testing, Blood Gas Testing & Others. By End-User are segmented in Clinics, Home, Laboratories, A
Breath Analyzer Market worth $1,167 million by 2025 texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.
Share:
ResearchAndMarkets.com s offering.
The global breath analyzer market is expected to reach USD 1,167 million by 2025 from USD 524 million in 2020, at a CAGR of 17.4%
Growth in the market can primarily be attributed to factors such as alcohol and drug abuse, stringent government regulations and increasing use of breathalyzers in detecting various diseases.
The fuel cell breathalyzer segment to hold the largest market share in 2020
Based on technology, the breath analyzers market is segmented into fuel cells, semiconductor oxide sensors, and other technologies (infrared spectroscopy and chemical crystals). In 2020, the fuel cells segment accounted for the largest share of the global breath analyzers market. Fuel cells are the most widely used technology in breath analyzers.
/PRNewswire/ If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this.
(AKER) - Akers Biosciences' Proposed Partner MyMD's Lead Candidate Inhibits Fibrotic Diseases-Associated Biomarkers benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.